Immunohistochemical diagnosis of MM is mostly based on melanocyte-specific markers such as PMEL, MLANA, or TYR, along with relatively unspecific and pleiotropic cancer biomarkers like S100B, and proliferation-related markers like MKI67 [17,18]. This evidence concerns the gene MLANA and Miyoshi myopathy.